Partners | Health Research Centres
Vall d’Hebron Institute of Oncology (VHIO)
Established in 2006, the Vall d´Hebron Institute of Oncology (VHIO) is a cancer research center of excellence dedicated to delivering on the promise of ´precision´ medicine in oncology - turning cancer discovery into more effective treatments and better practice for the care of patients. Its scientists and research physicians adopt a purely translational research model, working together as multidisciplinary teams to accelerate and advance personalized and targeted therapies against cancer.
VHIO´s suite of cutting-edge core technology platforms enable us to apply next-generation whole-genome sequencing for precision oncology. By sequencing panels of genes or entire genomes in cancer patients, we can identify specific molecular risk factors and gauge the potential efficacy of specific agents for individual patients. In parallel, these technologies (Hiseq2500, MiSeq, nCounter Nanostring), accelerate our research enabling the identification of mechanisms of resistance to targeted therapies, the study of clonal populations, and definition of novel therapeutic opportunities based on mutation profiles.